Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
5PSQ-149 Durvalumab for the treatment of non-small cell lung cancer: real-world experienceEuropean journal of hospital pharmacy. Science and practice, 2022-03, Vol.29 (Suppl 1), p.A164-A165 [Peer Reviewed Journal]European Association of Hospital Pharmacists 2022. No commercial re-use. See rights and permissions. Published by BMJ. ;2022 European Association of Hospital Pharmacists 2022. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 2047-9956 ;EISSN: 2047-9964 ;DOI: 10.1136/ejhpharm-2022-eahp.346Full text available |
|
2 |
Material Type: Article
|
5PSQ-085 Medication errors and pharmaceutical interventions for drugs administered by feeding tubeEuropean journal of hospital pharmacy. Science and practice, 2020-03, Vol.27 (Suppl 1), p.A189-A189 [Peer Reviewed Journal]Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ. ;2020 Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 2047-9956 ;EISSN: 2047-9964 ;DOI: 10.1136/ejhpharm-2020-eahpconf.402Full text available |
|
3 |
Material Type: Article
|
4CPS-142 Effectiveness and safety of anti-IL-5 biologic agents in severe eosinophilic asthmaEuropean journal of hospital pharmacy. Science and practice, 2020-03, Vol.27 (Suppl 1), p.A114-A115 [Peer Reviewed Journal]Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ. ;2020 Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 2047-9956 ;EISSN: 2047-9964 ;DOI: 10.1136/ejhpharm-2020-eahpconf.243Full text available |
|
4 |
Material Type: Article
|
5PSQ-050 Successful desensitisation in a patient with dasatinib hypersensitivityEuropean journal of hospital pharmacy. Science and practice, 2020-03, Vol.27 (Suppl 1), p.A172-A172 [Peer Reviewed Journal]Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ. ;2020 Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 2047-9956 ;EISSN: 2047-9964 ;DOI: 10.1136/ejhpharm-2020-eahpconf.367Full text available |
|
5 |
Material Type: Article
|
4CPS-102 Influence of palbociclib toxicity in real world clinical practiceEuropean journal of hospital pharmacy. Science and practice, 2020-03, Vol.27 (Suppl 1), p.A95-A95 [Peer Reviewed Journal]Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ. ;2020 Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 2047-9956 ;EISSN: 2047-9964 ;DOI: 10.1136/ejhpharm-2020-eahpconf.203Full text available |
|
6 |
Material Type: Article
|
4CPS-127 Economic impact of intensification regimens in inflammatory bowel diseaseEuropean journal of hospital pharmacy. Science and practice, 2020-03, Vol.27 (Suppl 1), p.A107-A107 [Peer Reviewed Journal]Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ. ;2020 Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 2047-9956 ;EISSN: 2047-9964 ;DOI: 10.1136/ejhpharm-2020-eahpconf.228Full text available |
|
7 |
Material Type: Article
|
4CPS-031 The primary efficacy endpoint for alirocumab, reductions in low-density lipoprotein cholesterolEuropean journal of hospital pharmacy. Science and practice, 2019-03, Vol.26 (Suppl 1), p.A81-A82 [Peer Reviewed Journal]2019, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions ;2019 2019, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions ;ISSN: 2047-9956 ;EISSN: 2047-9964 ;DOI: 10.1136/ejhpharm-2019-eahpconf.180Full text available |